Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol
- PMID: 15973779
- DOI: 10.1016/j.jhep.2005.01.022
Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol
Abstract
Background/aims: We analyzed the characteristics of HIV infected patients who died from liver disease, focusing on hepatitis virus co-infection.
Methods: One-hundred and eighty-five French hospital departments involved in HIV/AIDS management prospectively notified all deaths occurring in 2000. Patients whose hepatitis C (HCV) and hepatitis B (HBV) serostatus was known were classified as being infected by HCV alone, HBV alone (HBsAg positive), both HCV and HBV, or neither HCB nor HBV.
Results: Among 822 HIV infected patients, 29% were infected by HCV alone, 8% by HBV alone, and 4% by both HCV and HBV. The most frequent causes of death were liver disease (31% of cases) and AIDS (29%) among HIV-HCV co-infected patients, and AIDS (38%) and liver disease (22%) among HIV-HBV co-infected patients. Liver disease was a more frequent cause of death among patients co-infected by both HCV and HBV (44% of cases). Hepatocellular carcinoma was present in 15% of patients who died from liver disease, and was associated with HBV co-infection. Nearly half the patients who died from liver disease had more than 200 CD4/mm3.
Conclusions: Liver disease is now a leading cause of death among HIV-HCV co-infected patients and is becoming an important cause of death among HIV-HBV co-infected patients. The risk of death from liver disease is highest in patients co-infected by both HCV and HBV.
Comment in
-
Liver and AIDS mortality in HIV-infected patients.J Hepatol. 2005 Nov;43(5):911-2; author reply 912. doi: 10.1016/j.jhep.2005.07.012. Epub 2005 Aug 1. J Hepatol. 2005. PMID: 16171888 No abstract available.
Similar articles
-
[Research on the causes of death associated with combined effects of HBV and HCV infection in patients with acquired immunodeficiency syndrome].Zhonghua Gan Zang Bing Za Zhi. 2018 Jul 20;26(7):495-498. doi: 10.3760/cma.j.issn.1007-3418.2018.07.003. Zhonghua Gan Zang Bing Za Zhi. 2018. PMID: 30317770 Chinese.
-
Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004.Euro Surveill. 2008 May 29;13(22):18888. Euro Surveill. 2008. PMID: 18761958
-
Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.BMC Infect Dis. 2017 Mar 1;17(1):182. doi: 10.1186/s12879-017-2287-y. BMC Infect Dis. 2017. PMID: 28249574 Free PMC article. Review.
-
The impact of human immunodeficiency virus on viral hepatitis.Liver Int. 2011 Jan;31 Suppl 1:135-9. doi: 10.1111/j.1478-3231.2010.02394.x. Liver Int. 2011. PMID: 21205151 Review.
-
Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study.J Hepatol. 2009 Apr;50(4):736-45. doi: 10.1016/j.jhep.2008.11.018. Epub 2009 Jan 3. J Hepatol. 2009. PMID: 19231018
Cited by
-
Porphyromonas gingivalis induces CCR5-dependent transfer of infectious HIV-1 from oral keratinocytes to permissive cells.Retrovirology. 2008 Mar 27;5:29. doi: 10.1186/1742-4690-5-29. Retrovirology. 2008. PMID: 18371227 Free PMC article.
-
Residual immune dysfunction under antiretroviral therapy.Semin Immunol. 2021 Jan;51:101471. doi: 10.1016/j.smim.2021.101471. Epub 2021 Mar 3. Semin Immunol. 2021. PMID: 33674177 Free PMC article. Review.
-
Characterisation of HBV and co-infection with HDV and HIV through spatial transcriptomics.eGastroenterology. 2024 Aug;2(3):e100067. doi: 10.1136/egastro-2024-100067. Epub 2024 Jul 11. eGastroenterology. 2024. PMID: 39149129 Free PMC article.
-
Impact of immunodepression and moderate alcohol consumption on coronary and other arterial disease events in an 11-year cohort of HIV-infected patients on antiretroviral therapy.BMJ Open. 2012 Nov 23;2(6):e001155. doi: 10.1136/bmjopen-2012-001155. Print 2012. BMJ Open. 2012. PMID: 23180454 Free PMC article.
-
The Tat protein of human immunodeficiency virus-1 enhances hepatitis C virus replication through interferon gamma-inducible protein-10.BMC Immunol. 2012 Apr 3;13:15. doi: 10.1186/1471-2172-13-15. BMC Immunol. 2012. PMID: 22471703 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials